TECTONIC THERAPEUTIC, INC. Restricted Cash and Cash Equivalents
TECTONIC THERAPEUTIC, INC. (TECX) had Restricted Cash and Cash Equivalents of $492.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-03-16
- 2019-12-31: Restricted Cash and Cash Equivalents $492.00K.
- 2018-12-31: Restricted Cash and Cash Equivalents $492.00K.
- 2017-12-31: Restricted Cash and Cash Equivalents $24.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2019-12-31 | $492.00K 10-K · filed 2020-03-16 |
| 2018-12-31 | $492.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $24.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |